EAM
ROIV icon

Exos Asset Management’s Roivant Sciences ROIV Stock Holding History

Exos Asset Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$64K Hold
15,724
– – 0.03% 186
2022
Q1 		$78K Sell
15,724
-5,100
-24% -$33.6K 0.03% 221
2021
Q4 		$210K Buy
+20,824
New +$173K 0.11% 172

Other funds holding ROIV

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
PT
Palantir Technologies Denver, Colorado $9.72M AUM 6.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return

Exos Asset Management's ROIV Position: Q2 2022 in Review

Exos Asset Management held its Roivant Sciences (ROIV) position steady in Q2 2022 at 15,724 shares worth $64K. The position accounts for 0.03% of the portfolio, ranked #186.

Exos Asset Management first reported a position in ROIV in Q4 2021 and has held it in 3 quarters since. The position peaked at $210K in Q4 2021. 71 funds tracked by Wall St. Rank hold ROIV as of Q2 2022.

  • Exos Asset Management held 15,724 shares of Roivant Sciences worth $64K as of Q2 2022.
  • Exos Asset Management left its Roivant Sciences share count unchanged in Q2 2022.
  • Roivant Sciences made up 0.03% of Exos Asset Management's portfolio in Q2 2022, its #186 holding.
  • Exos Asset Management first reported a position in Roivant Sciences in Q4 2021 and has held it in 3 quarters since.
  • Exos Asset Management's Roivant Sciences position peaked at $210K in Q4 2021.
  • 71 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2022.

Based on Exos Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.